Search Within

Stephen Wayne Gilheeney

Refine Results
Formats
  1. Meeting Abstract (35)
  2. Journal Article (27)
Groups
  1. Neuro-Oncology Service (62)
  2. Pediatrics, Department of (62)
  3. Survivorship Research (49)
  4. Center for Hematologic Malignancies (35)
  5. Pediatric Leukemia (35)
  6. Radiation Oncology, Department of (26)

More Groups

People
  1. Ira Dunkel (46)
  2. Yasmin Khakoo (40)
  3. Suzanne Wolden (26)
  4. Kim Kramer (21)
  5. Mark Souweidane (20)
  6. David Lyden (18)

More People

Years
  1. 2020 (6)
  2. 2019 (3)
  3. 2018 (7)
  4. 2017 (6)
  5. 2016 (6)
  6. 2015 (1)

More Years

Publications
  1. Neuro-Oncology (28)
  2. Pediatric Blood and Cancer (10)
  3. Journal of Neuro-Oncology (5)
  4. International Journal of Radiation Oncology, Biology, Physics (4)
  5. Journal of Pediatric Hematology/Oncology (3)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Oxford University Press (29)
  2. Wiley Periodicals, Inc (10)
  3. Elsevier Inc. (6)
  4. Springer (6)
  5. Lippincott Williams & Wilkins (4)
  6. American Association for Cancer Research (2)

More Publishers

Results (62)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DEBIO1347, an oral FGFR inhibitor: Results from a single center study in recurrent/refractory FGFR altered pediatric gliomas
    Meeting Abstract

    Sait, S. F.; Gilheeney, S.; Dunkel, I.; Karajannis, M.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • DEBIO1347, an oral FGFR inhibitor: Results from a single center study in recurrent/refractory FGFR altered pediatric gliomas
    Meeting Abstract

    Karajannis, M.; Sait, S.; Gilheeney, S.; Haque, S.; Dunkel, I.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Debio1347, an oral FGFR inhibitor: Results from a single center study in pediatric patients with recurrent/refractory FGFR altered gliomas
    Meeting Abstract

    Sait, S. F.; Rosenblum, M.; Bale, T.; Haque, S.; Gilheeney, S.; Spatz, K.; Prince, D.; Ibanez, K.; Dunkel, I.; Karajannis, M.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • The integration of a liquid biopsy program into the care of pediatric brain tumor patients
    Meeting Abstract

    Miller, A.; Szalontay, L.; Ahmad, H.; Bouvier, N.; Rodriguez-Sanchez, I.; Bale, T.; Benayed, R.; Arcila, M.; Donzelli, M.; Dunkel, I.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
    Journal Article

    Clarke, M.; Mackay, A.; Ismer, B.; Pickles, J. C.; Tatevossian, R. G.; Newman, S.; Bale, T. A.; Stoler, I.; Izquierdo, E.; Temelso, S.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas
    Journal Article

    Ryall, S.; Zapotocky, M.; Fukuoka, K.; Nobre, L.; Guerreiro Stucklin, A.; Bennett, J.; Siddaway, R.; Li, C.; Pajovic, S.; Arnoldo, A.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save
  • Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes
    Meeting Abstract

    Bailey, K.; Pandit-Taskar, N.; Humm, J.; Zanzonico, P.; Gilheeney, S.; Cheung, N. K.; Kramer, K.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features of non-canonical molecular drivers in pLGG; an update form the international pLGG Taskforce
    Meeting Abstract

    Ryall, S.; Zapotocky, M.; Fukuoka, K.; Guerreiro-Stucklin, A.; Bennett, J.; Arnoldo, A.; Kowalski, P.; Johnson, M.; Nobre, L. F.; Lassaletta, A.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes
    Journal Article

    Bailey, K.; Pandit-Taskar, N.; Humm, J. L.; Zanzonico, P.; Gilheeney, S.; Cheung, N. K. V.; Kramer, K.
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Phase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600-mutant high-grade glioma (HGG) or low-grade glioma (LGG)
    Meeting Abstract

    Hargrave, D.; Witt, O.; Cohen, K.; Packer, R.; Lissat, A.; Kordes, U.; Laetsch, T. W.; Hoffman, L.; Lassaletta, A.; Gerber, N. U.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save